Dr. Fakih is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673- Is this information wrong?
Education & Training
UPMC Medical EducationFellowship, 1998 - 2001
Wayne State University School of MedicineResidency, 1992 - 1995
American University of Beirut Faculty of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 2012 - 2025
MI State Medical License 1994 - 2015
NY State Medical License 2002 - 2011
PA State Medical License 1997 - 2002- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Start of enrollment: 2023 Jul 27
Roles: Contact
- Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Start of enrollment: 2021 Apr 11
Roles: Contact
- Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy Start of enrollment: 2023 May 11
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique.Darrell Fan, Matthew C Hernandez, Jaideep Sandhu, Kelly Mahuron, Jonathan Kessler, Mustafa Raoof, Marwan Fakih, Gagandeep Singh, Yuman Fong, Laleh G Melstrom> ;Journal of Surgical Oncology. 2024 Mar 20
- 26 citationsPembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study.Marabelle, A., Cassier, P., Fakih, M., Kao, S., Nielsen, D., Italiano, A., Guren, T., van Dongen, M., Spencer, K., Bariani, G., Ascierto, P., Santoro, A., Shah, M., As...> ;The Lancet. Gastroenterology & Hepatology. 2022 May 1
- 4 citationsA Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune ResponsesJoseph Chao, Ting-Fang He, Massimo D'Apuzzo, Yi-Jen Chen, Paul Frankel, Michael Tajon, Helen Chen, Shawn Solomon, Samuel J. Klempner, Peter P. Lee, Marwan Fakih> ;Advances in Radiation Oncology. 2022 Jan 1
- Join now to see all
Press Mentions
Surge in Colon Cancer: What Gen X, Millennials and Gen Zer’s Need to KnowMarch 6th, 2024
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
